The major goal of the Neuropathology (NP) core of the Rush ADC is to provide investigators with well preserved brain tissue and complete diagnostic neuropathological evaluations from clinically well-characterized study participants. Provision of such tissue is necessary in order to fulfill the overall goal of the ADC to promote scientific investigations of Alzheimer's disease (AD).
The specific aims of the NP Core are to: 1. Obtain brain tissue from clinically well-characterized elderly individuals with Alzheimer?s disease, corresponding closely-matched control patients, and other neurological disease control cases through close collaboration with the Clinical and Religious Orders Study Cores; 2. Obtain the brain tissue with minimal postmortem intervals, preserved and processed in a standard and uniform fashion so that it can be used in various experimental protocols by a variety of investigators; 3. Perform a thorough and detailed neuropathological evaluation using standard, up-to-date, consistent diagnostic criteria for AD, Parkinson's disease (PD) and related disorders; 4. Reliably store and index the tissue and data, allowing for accurate and rapid information retrieval and tissue distribution to investigators. The ROS core is the source of clinical and pathological data and brain specimens which are especially valuable to investigators. It is composed of elderly Catholic clergy who volunteer to be neurologically and neuropsychologically examined each year, and consent to brain autopsy upon their death. The NP core has received, processed, preserved, and evaluated 130 brain autopsies from the subjects of the ROS core. Clinically, the group is composed of 37% with no cognitive impairment, 21% with mild cognitive impairment, and 42% with dementia. The NP core finds this brain tissue to be an extremely important resource for studies of both AD and aging-associated changes in the brain, as well as their inter-relationship.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Center Core Grants (P30)
Project #
3P30AG010161-11S2
Application #
6563292
Study Section
Project Start
2002-03-01
Project End
2002-06-30
Budget Start
1998-10-01
Budget End
1999-09-30
Support Year
11
Fiscal Year
2002
Total Cost
$178,517
Indirect Cost
Name
Rush University Medical Center
Department
Type
DUNS #
City
Chicago
State
IL
Country
United States
Zip Code
60612
Yang, Hyun-Sik; Yu, Lei; White, Charles C et al. (2018) Evaluation of TDP-43 proteinopathy and hippocampal sclerosis in relation to APOE ?4 haplotype status: a community-based cohort study. Lancet Neurol 17:773-781
Agogo, George O; Ramsey, Christine M; Gnjidic, Danijela et al. (2018) Longitudinal associations between different dementia diagnoses and medication use jointly accounting for dropout. Int Psychogeriatr 30:1477-1487
Tasaki, Shinya; Gaiteri, Chris; Mostafavi, Sara et al. (2018) Multi-omic Directed Networks Describe Features of Gene Regulation in Aged Brains and Expand the Set of Genes Driving Cognitive Decline. Front Genet 9:294
Pruzin, J J; Nelson, P T; Abner, E L et al. (2018) Review: Relationship of type 2 diabetes to human brain pathology. Neuropathol Appl Neurobiol 44:347-362
De Jager, Philip L; Ma, Yiyi; McCabe, Cristin et al. (2018) A multi-omic atlas of the human frontal cortex for aging and Alzheimer's disease research. Sci Data 5:180142
Montagne, Axel; Nikolakopoulou, Angeliki M; Zhao, Zhen et al. (2018) Pericyte degeneration causes white matter dysfunction in the mouse central nervous system. Nat Med 24:326-337
Barnes, Josephine; Bartlett, Jonathan W; Wolk, David A et al. (2018) Disease Course Varies According to Age and Symptom Length in Alzheimer's Disease. J Alzheimers Dis 64:631-642
Dobbyn, Amanda; Huckins, Laura M; Boocock, James et al. (2018) Landscape of Conditional eQTL in Dorsolateral Prefrontal Cortex and Co-localization with Schizophrenia GWAS. Am J Hum Genet 102:1169-1184
Wang, Xulong; Philip, Vivek M; Ananda, Guruprasad et al. (2018) A Bayesian Framework for Generalized Linear Mixed Modeling Identifies New Candidate Loci for Late-Onset Alzheimer's Disease. Genetics 209:51-64
Alosco, Michael L; Sugarman, Michael A; Besser, Lilah M et al. (2018) A Clinicopathological Investigation of White Matter Hyperintensities and Alzheimer's Disease Neuropathology. J Alzheimers Dis 63:1347-1360

Showing the most recent 10 out of 786 publications